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Abstract
Background: Exposure to respirable crystalline silica particles, as opposed to amorphous silica, is associated with
lung inflammation, pulmonary fibrosis (silicosis), and potentially with lung cancer. We used Affymetrix/GeneSifter
microarray analysis to determine whether gene expression profiles differed in a human bronchial epithelial cell line
(BEAS 2B) exposed to cristobalite vs. amorphous silica particles at non-toxic and equal surface areas (75 and 150 ×
10
6μm
2/cm
2). Bio-Plex analysis was also used to determine profiles of secreted cytokines and chemokines in
response to both particles. Finally, primary human bronchial epithelial cells (NHBE) were used to comparatively
assess silica particle-induced alterations in gene expression.
Results: Microarray analysis at 24 hours in BEAS 2B revealed 333 and 631 significant alterations in gene expression
induced by cristobalite at low (75) and high (150 × 10
6μm
2/cm
2) amounts, respectively (p < 0.05/cut off ≥ 2.0-fold
change). Exposure to amorphous silica micro-particles at high amounts (150 × 10
6μm
2/cm
2) induced 108
significant gene changes. Bio-Plex analysis of 27 human cytokines and chemokines revealed 9 secreted mediators
(p < 0.05) induced by crystalline silica, but none were induced by amorphous silica. QRT-PCR revealed that
cristobalite selectively up-regulated stress-related genes and cytokines (FOS, ATF3, IL6 and IL8) early and over time
(2, 4, 8, and 24 h). Patterns of gene expression in NHBE cells were similar overall to BEAS 2B cells. At 75 × 10
6μm
2/
cm
2, there were 339 significant alterations in gene expression induced by cristobalite and 42 by amorphous silica.
Comparison of genes in response to cristobalite (75 × 10
6μm
2/cm
2) revealed 60 common, significant gene
alterations in NHBE and BEAS 2B cells.
Conclusions: Cristobalite silica, as compared to synthetic amorphous silica particles at equal surface area
concentrations, had comparable effects on the viability of human bronchial epithelial cells. However, effects on
gene expression, as well as secretion of cytokines and chemokines, drastically differed, as the crystalline silica
induced more intense responses. Our studies indicate that toxicological testing of particulates by surveying viability
and/or metabolic activity is insufficient to predict their pathogenicity. Moreover, they show that acute responses of
the lung epithelium, including up-regulation of genes linked to inflammation, oxidative stress, and proliferation, as
well as secretion of inflammatory and proliferative mediators, can be indicative of pathologic potential using either
immortalized lines (BEAS 2B) or primary cells (NHBE). Assessment of the degree and magnitude of these responses
in vitro are suggested as predictive in determining the pathogenicity of potentially harmful particulates.
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Occupational and environmental exposure to fine and
ultrafine particulates is rapidly becoming an overwhelm-
ing area of concern. With increasing numbers and com-
positional heterogeneity of potentially harmful natural
and synthetic particulates, there is a vital need for
screening assays to determine their potential pathogeni-
city. Crystalline silica particles are known to cause sili-
cosis (a pneumoconiosis) and have other detrimental
respiratory effects when inhaled in excessive amounts
[1]. Airborne exposures are also associated with lung
inflammatory diseases, increased susceptibility to infec-
tion, as well as lung cancers, especially in smokers [2,3].
Crystalline silica was stated to be a Class I carcinogen
(IARC 1997) which was recently restated (IARC 2010)
[4], though epidemiologic data are inconsistent, and its
carcinogenic potential in non-smokers remains contro-
versial [5]. Exposure to crystalline silica is associated
with industries and occupations including, sandblasting,
ceramics, cement manufacture, construction, and quarry
and foundry workers [2,6-9]. Although crystalline silica
exists in many different polymorphs, those of particular
concern are the naturally occurring polymorphs quartz,
cristobalite and tridymite [10]. Cristobalite was used in
studies here because of its bioreactivity in a rat inhala-
tion model [11].
Inhalation of crystalline silica or other pathogenic
minerals such as asbestos and airborne particulate mat-
ter (PM) results in lung injury by mechanisms, which
are not well understood [12,13]. Crystalline silica parti-
cles induce extensive inflammatory and proliferative
effects in vitro and in vivo [14-20]. Activation of several
signaling pathways, including the mitogen-activated pro-
tein kinases (MAPKs) [21-23] as well as transcription
factor complexes including activator protein-1 (AP-1)
[24] and nuclear factor kappa B (NFB), are thought to
contribute to the pro-inflammatory, toxic and mitogenic
effects of silica [25]. Understanding the broad spectrum
of initial events induced by particulate-cell interactions
is crucial to revealing the molecular mechanisms that
contribute to inflammation, abnormal proliferation and
cross-talk between epithelial cells and other cell types in
the lung.
Here we focused on lung epithelial cells, which initi-
ally interact with respirable particles after inhalation to
provide insight into molecular events initiating silica-
induced disease processes. Since surface area, as
opposed to equal mass concentration, has been shown
to be a more appropriate parameter of dosing to deter-
mine the effects of fine and ultrafine particulates in bio-
logical systems [26-29], human bronchial epithelial cells
were exposed to crystalline silica (cristobalite) or amor-
phous silica (synthetic, dense silica spheres) at non-toxic
and equal surface area concentrations. As previous stu-
dies from our group have shown that the magnitude
and duration of gene expression alterations in human
mesothelial cells by asbestos fibers may be predictive of
their pathogenic potential [30-32], we utilized robust
microarray profiling to compare responses of human
lung epithelial cells to pathogenic crystalline vs. amor-
phous silica. Our findings link the extent of changes in
gene expression and cytokine production to silica crys-
tallinity and pathogenicity in silicosis.
Results and Discussion
Cristobalite and amorphous silica particles have equal
effects on viability of BEAS 2B cells
Surface area is a better metric than mass, thus doses
have been measured on a surface area basis as the biolo-
gical activity of particles is largely based on their respec-
tive surface characteristics [29,33-35]. Much of this is
accredited to the ability of pathogenic particles to pro-
duce reactive oxygen and nitrogen species (ROS and
RNS) [36] that promote inflammatory responses and
cellular injury [37]. The surface areas of cristobalite and
amorphous silica particles (dense silica micro-spheres)
were determined by BET nitrogen adsorption analysis
[32]. Table 1 presents the surface area/unit mass (m
2/g)
and other properties of cristobalite and amorphous silica
particles, including chemical composition (SiO2), which
is confirmed in (Additional file 1) by SEM-EDS analysis.
In addition, the size distribution of cristobalite and
amorphous silica particles was determined (Additional
file 2). It should be noted that in these studies, a specific
type of amorphous silica was used (micron-sized, dense,
spheres synthesized by hydrolysis reactions) and there-
fore conclusions may not necessarily be extrapolated to
other amorphous silica types. To avoid use of lethal
concentrations of particles, we first performed cell viabi-
lity assays over a range of concentrations. Both particles
Table 1 Silica particle characterization
Silica Particle Chem. Comp. % Purity S.A. (m
2/g)
a Mean size (μm)
b Particles/mg Source
Cristobalite SiO2 *95.5 ± 0.03 5.1 2.16 ± 2.00 - C&E Mineral Corp, King of Prussia, PA
Amorphous SiO2 > 99 2.2 3.55 ± 0.45 20.33 × 10
6 University of Vermont, Dept. of Chemistry
Table 1 summarizes silica particle characterization of cristoablaite and amorphous silica particles.
a S.A. = Surface area/mass (m
2/g).
b Mean particle diameter ± standard deviation
* Sample contains traces of quartz (4.54 ± 0.08%)
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Page 2 of 18had dose-responsive effects on viability, inducing only
about 15% loss of viability (non-significant) at highest
concentrations (150 × 10
6μm
2/cm
2)o v e ra2 4hp e r i o d
(Figure 1). Both a low (75 × 10
6μm
2/cm
2) and high dose
(150 × 10
6μm
2/cm
2) of crystalline silica particles and a
high dose (150 × 10
6μm
2/cm
2) of amorphous silica were
evaluated by microarray and Bio-Plex analysis for gene
expression and cytokine/chemokine secretion,
respectively.
Cristobalite and amorphous silica particles interact with
and are taken up by BEAS 2B cells
To determine whether human lung epithelial cells took
up both particle types, scanning electron micrographs of
BEAS 2B cells exposed to silica particles (75 × 10
6μm
2/
cm
2)w e r ee x a m i n e da t2a n d2 4h( F i g u r e2 ) .T h ep r e -
sence of silica particles was confirmed by electron dis-
persion spectroscopy (EDS) analysis, in which a
spectrum was taken of a point “on-particle” showing a
strong silicon (Si) peak and an “off-particle” spectrum,
which contained no (Si) peak. Both cristobalite and
amorphous silica particles interacted with cells at 2 h
and were internalized by 24 h (Figure 2). No major
toxic effects were observed, correlating with results of
cell viability studies. Based on these results, we investi-
gated alterations in gene expression and mediator secre-
tion at these non-toxic particle doses.
Microarray analysis reveals robust changes in gene
expression profiles in BEAS 2B cells exposed to
cristobalite vs. amorphous silica particles
It has been shown both in vitro and in vivo that crystal-
line silica particles are more biologically active and
pathogenic than amorphous silica particles [20,38-40].
Therefore, we sought to determine if there were signifi-
cant differences in how different silica particles (crystal-
line vs. amorphous) would affect gene expression and
cytokine/chemokine secretion at equal surface area con-
centrations in the BEAS 2B immortalized cell line. Affy-
metrix/GeneSifter analysis of BEAS 2B cells exposed to
cristobalite silica at 75 and 150 × 10
6μm
2/cm
2 were
compared to patterns using amorphous silica particles at
150 × 10
6μm
2/cm
2 for 24 h, the time point of maximum
gene expression observed with pathogenic particulates in
previous studies using human mesothelial cells exposed
to asbestos [30-32], primary human airway epithelial
cells exposed to PM fractions [41] or chrysotile asbestos
[42]. A dose-responsive pattern was observed with cris-
tobalite silica that induced a total of 333 and 631 signifi-
cant gene changes at 75 and 150 × 10
6μm
2/cm
2,
respectively (p < 0.05 with a cut-off of ≥ 2.0-fold change
compared to controls). In addition, expression of certain
genes was dose-responsive as well. For instance, matrix
metallopeptidase 1 (MMP1)g e n ee x p r e s s i o nw a s
increased 16-fold and 44-fold at 75 and 150 × 10
6μm
2/
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(μg/cm2)b 
   Control        15           75           150 
   Control       2.94       14.71        29.4
    Control        15           75           150
Control       6.82        34.1         68.2
a Surface area concentration
b Mass concentration 
Control
Cristobalite silica
Amorphous silica
Figure 1 Assessment of BEAS 2B cell viability after exposure to silica particles. Cell viability assessed by the Trypan blue exclusion assay of
cells exposed to cristobalite (A) and amorphous silica particles (B) for 24 h. Results are expressed as the mean percent viable cells ± SEM
compared to unexposed controls and are representative of 3 independent experiments (N = 3 for each group in each experiment).
a denotes
the surface area concentrations expressed as (x10
6μm
2/cm
2) and
b denotes the respective mass concentrations of particles used (μg/cm
2).
Concentrations presented are represented by surface area for all other figures and tables.
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2, respectively (Table 2). This dose responsive trend
was observed overall in mRNA levels of the 10 most
highly expressed genes after cristobalite exposures as
presented in Table 2. However, amorphous silica parti-
cles, at the highest surface area concentration (150 ×
10
6μm
2/cm
2), induced only 108 significant gene changes,
nearly 6-fold less than cristobalite silica (Figure 3A). Of
the 108 changes induced by amorphous silica, 93 of
these changes were also induced by cristobalite silica at
the same concentration.
Gene ontology (GO) analysis then was used to cate-
gorize changes in gene expression caused by silica
50 μm
50 μm
50 μm
50 μm
50 μm
10 μm
10 μm
10 μm
10 μm
10 μm
Control Control
Cris 2h Cris 2h
Cris 24h Cris 24h
Amor 2h Amor 2h
Amor 24h Amor 24h
50 μm
Control
10 μm
Control
10 μm
Cris 2h
10 μm
Cris 24h
Amor 2h
50 μm
Cris 2h
50 μm
Cris 24h
Figure 2 Interaction and uptake of silica particles by BEAS 2B cells. Scanning Electron Micrographs of BEAS 2B cells. Unexposed controls (A,
B), exposed to cristobalite (75 × 10
6μm
2/cm
2) for 2 h (C, D), 24 h (E, F) and amorphous silica (75 × 10
6μm
2/cm
2) for 2 h (G, H) and 24 h (I, J).
Panels on the left are at low magnification (500×) scale bar = 50 μm and on the right at high magnification (2500×) scale bar = 10 μm. White
arrows indicate silica particles.
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interest (cell signaling, cell adhesion, cell proliferation,
apoptosis, regulation of programmed cell death, protein
metabolic processes, immune response, cell motility,
oxidation-reduction, and cell matrix adhesion) were
used to classify gene changes [30-32]. Interestingly, pat-
terns of both cristobalite silica and amorphous silica-
induced mRNA expression were similar, with most gene
expression alterations related to cell signaling and prolif-
eration, apoptosis, protein metabolic processes and
immune responses. Though the intensity of gene
changes (both in number and magnitude or fold-change)
was dose-dependent, overall the same patterns of change
were seen (Additional file 3). These five categories
account for 77, 73 and 80% of gene changes in BEAS 2B
cells exposed to cristobalite at 75 and 150 × 10
6μm
2/
cm
2 and amorphous silica at 150 × 10
6μm
2/cm
2,
respectively.
Table 2 lists the top 10 gene changes induced by cris-
tobalite vs. amorphous silica. The majority of the top 10
up-regulated genes are related to immune response
(OAS1, OAS2, OASL, IFI44, IFI44L, BLNK), apoptosis
(MX1, BTG2, IL24 and IFI27) cell signaling (MX2)a n d
dissolution of extracellular matrix (MMP1). These genes
may contribute to the development of silicosis or, in the
case of MMP1, repair of lung injury. Similar changes in
Table 2 Top 10 genes affected by 24 h exposure to silica particles in BEAS 2B
Gene Name (Abbreviation) Fold Change
a
Cristobalite Amorphous
75
b 150
b 150
b
Up-regulated ▲
Myxovirus (influenza virus) resistance 2 (mouse) (MX2) 20.86 73.76 22.33
Matrix metallopeptidase 1 (interstitial collagenase) (MMP1) 16.12 44.68 18.75
Sodium Channel, voltage-gated, type III, beta (SCN3B) 15.33 20.54 NC
2’-5’-oligoadenylate-synthetase 2, 69/71kDa (OAS2) 13.56 34.77 12.17
Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1) 9.61 23.33 8.72
Interferon-induced protein 44-like (IFI44L) 7.64 22.82 8.63
Interferon-induced protein 44 (IFI44) 7.51 19.90 8.24
B-cell Linker (BLNK) 7.24 9.32 NC
BTG family, member 2 (BTG2) 7.22 8.56 NC
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) 7.19 11.05 NC
2’-5’-oligoadenylate synthetase 1, 40/46kDa (OAS1) 7.09 20.53 6.75
Interferon, alpha-inducible protein 27 (IFI27) 6.59 17.62 6.15
2’-5’-oligoadenylate synthetase-like (OASL) 6.80 18.85 6.92
Radical S-adenosyl methionine domain containing (RSAD1) 5.45 23.25 6.09
Interleukin 24 (IL24) 3.88 8.54 6.47
Down-regulated ▼
Collagen, type I, alpha 2 (COL1A2) 6.08 10.86 2.12
Hypoxia inducible factor 3, alpha subunit (HIF3A) 4.51 7.18 3.94
Collagen, type I, alpha 1 (COL1A1) 4.17 5.52 NC
Methyltransferase like 7A (METTL7A) 4.11 5.67 2.89
Cytochrome P450, family 4, subfamily B, polypeptide 1 (CYP4B1) 3.93 5.55 3.07
Olfactomedin-like 3 (OLFML3) 3.91 5.28 2.06
Mitogen-activated protein kinase kinase 6 (MAP2K6) 3.86 4.78 3.21
Collagen, type XI, alpha 1 (COL11A1) 3.85 5.46 NC
Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16) 3.78 7.11 3.49
Cannabinoid receptor 1 (brain) (CNR1) 3.75 5.44 3.48
Calcium channel, voltage-dependent, alpha 2/delta subunit 3 (CACNA2D3) 3.53 3.49 2.65
Solute carrier family 38, member 4 (SLC38A4) 3.16 3.76 2.65
Leucine rich repeat containing 17 (LRRC17) 3.14 5.07 3.61
Protocadherin 9 (PCDH9) 2.98 3.69 2.65
Top 10 genes in BEAS 2B cells up and down-regulated by 24-hour exposure to cristobalite silica at 75 and 150 × 10
6μm
2/cm
2 and amorphous silica particles at
150 × 10
6 μm
2/cm
2.
a Fold change (mRNA) expression (p < 0.05) cut-off ≥ 2.0-fold compared to controls (n = 3).
b Silica particle concentrations: (× 10
6μm
2/cm
2)
NC = No Change
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Page 5 of 18gene expression were observed in a recent study investi-
gating common gene expression responses of macro-
phages to a number of pathogens including toll-like
receptor (TLR) agonists, Salmonella, and silica nanopar-
ticles in which the authors described a “macrophage
core response module” [43]. Common changes com-
pared with results in Table 2 include: MX1, MX2,
OAS1, OAS2,a n dIFI44. In our studies, several other
genes included in this “macrophage core response mod-
ule” were also altered in expression (p < 0.05) by cristo-
balite including EGR1, EGR2, FOS, GADD45B, IFIT1,
IFIT2, JUN, MAFB, PLAU,a n dPTGS1. These results
indicate that foreign materials consistently affect a num-
ber of common genes in both macrophages and lung
epithelial cells. The specific roles these genes play in the
development of lung disease is not well understood;
however, they appear to be elicited in acute responses to
foreign materials and infectious agents. How these rapid
responses affect epithelial cells and macrophages,
respectively as well as cross-talk between these cells, is
not understood, but they may be important, initial
mechanisms of cell response to crystalline silica.
Steady state mRNA levels of stress-related and
inflammatory genes are induced early and selectively by
cristobalite in BEAS 2B cells
Based on the results of our microarray analyses, we
investigated some genes of interest using qRT-PCR to
confirm changes found in microarrays as well as to
determine their time-course of induction in BEAS 2B
cells. Genes investigated (up-regulated by cristobalite at
75 and 150 × 10
6μm
2/cm
2 in microarray) included the
-40 
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Figure 3 Microarray analysis of BEAS 2B cells in response to silica particle exposure (24 h).( A) Total number of significant gene changes
(p < 0.05) with a cut-off of ≥ 2.0-fold change in mRNA compared to unexposed controls in BEAS 2B exposed for 24 h (total number of gene
changes). Gene ontology analysis of BEAS 2B exposed to (B) Cristobalite at 75 × 10
6μm
2/cm
2,( C) 150 × 10
6μm
2/cm
2 and (D) amorphous silica at
150 × 10
6μm
2/cm
2. Positive values represent number of genes up-regulated (Black bars) and negative values represent number of genes down-
regulated (white bars) (N = 3).
Perkins et al. Particle and Fibre Toxicology 2012, 9:6
http://www.particleandfibretoxicology.com/content/9/1/6
Page 6 of 18early response gene FOS (2.12, 3.51-fold), a member of
the activator protein-1 (AP-1) transcription factor com-
plex [44], activating transcription factor 3 ATF3 (2.68,
3.16-fold), which is up-regulated in gene-profiling by
several particulates in human mesothelial cells and pri-
mary bronchial epithelial cells [30-32,42], and the pro-
inflammatory cytokines IL6 (2.12, 2.59-fold) and IL8
(2.12, 2.65-fold), both shown to be up-regulated by crys-
talline silica in A549 cells and a number of in vitro and
in vivo models [21,45-49].
In all cases, mRNA levels of these genes were only up-
regulated significantly by crystalline in contrast to amor-
phous silica (Figure 4). Consistent with its role as an
e a r l yr e s p o n s eg e n e ,FOS expression was significantly
increased at 2 h and peaked at 4 h post-exposure to
silica (Figure 4A). These findings indicate that stress-
response genes are rapidly activated by crystalline silica
but not by amorphous silica particles in human lung
epithelial cells. It has previously been demonstrated that
FOS expression is increased by alpha quartz (DQ12 and
Min-U-Sil), and coal-mine dust with high quartz con-
centrations in a murine alveolar type II cell line (C10)
[23,50]. In addition, ATF3 was significantly up-regulated
by crystalline silica as early as 4 and up to 24 h (Figure
4B). In studies investigating gene expression induced by
asbestos in human mesothelial and bronchial epithelial
cells [31,32,42,51], as well as by cigarette smoke extract
in 3T3 fibroblasts [52] and benzo(a)pyrine diol-epoxide
(BPDE) in bronchial epithelial cells [42], ATF3 expres-
sion is significantly increased. Moreover, Shukla et al.
[32], demonstrated that ATF3 expression was causally
linked to the release of cytokines from human mesothe-
lial cells exposed to asbestos fibers using siRNA
approaches.
To our knowledge, up-regulation of ATF3 by crystal-
line silica particles has not been reported previously. It
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Page 7 of 18is possible, based on our earlier work [32] and results
below, that ATF3 may be linked to secreted-mediator
release from bronchial epithelial cells. For example, IL6
and IL8, which are linked to early inflammatory
response, are up-regulated at the mRNA level and
released from lung epithelial cells, alveolar macrophages,
and in BALF of mice exposed to crystalline silica
[21,45-48]. Our studies show that IL6 and IL8 mRNA
levels are up-regulated significantly (p < 0.05) at 4, 8,
and 24 h by cristobalite (Figure 4C, D). In summary,
data in Figure 4 show that stress-response and pro-
inflammatory genes are up-regulated early and over
time, peaking at 4 h, in human bronchial epithelial cells
by crystalline, but not amorphous silica particles. As
both particle types are similar in size and chemical
composition, non-toxic to, and taken up by BEAS 2B
cells, their differential effects on gene expression may be
related to differences in crystallinity.
Cristobalite silica selectively induces pro-inflammatory
and angiogenic cytokine and chemokine secretion from
BEAS 2B cells
Figure 5 shows the results of Bio-Plex assays. Levels of 9
cytokines/chemokines in medium were increased (p <
0.05) selectively by cristobalite and 2 were decreased by
both silica types when compared to unexposed control
cells. As for the remainder of the 27 cytokines and che-
mokines surveyed, 8 (IFNg,I P - 1 0 ,I L - 1 b,I L - 7 ,I L - 9 ,I L -
10, MIP-1a and MIP-1b) yielded insignificant changes
when compared to unexposed controls, and 8 (IL-1ra,
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Figure 5 Bio-Plex analysis of secreted cytokines and chemokines in medium of BEAS 2B cells exposed to silica particles 24 h. Cell-free
conditioned medium of BEAS 2B exposed to silica particles for 24 h was assayed for 27 cytokines and chemokines. Presented in this panel are
the 11 which yielded significant differences from untreated controls in levels of secreted proteins: Interleukin-6 (IL-6), Interleukin-8 (IL-8),
Interleukin-12 (p70) (IL-12 (p70)), Interleukin-13 (IL-13), Interleukin-15 (IL-15), Monocyte chemotactic protein-1 (MCP-1 or MCAF), Regulated upon
activation, normal T-cell expressed and secreted (RANTES), Granulocyte-colony stimulating factor (G-CSF), Basic fibroblast growth factor (bFGF),
Platelet derived growth factor-BB (PDGF-BB) and Vascular endothelial growth factor (VEGF). White bars (unexposed controls), black bars
(cristobalite silica) and gray bars (amorphous silica), N = 3. * (P < 0.05) vs. unexposed controls, †P < 0.05 vs. amorphous silica.
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Page 8 of 18IL-2, IL-4, IL-5, IL-17, Eotaxin, GM-CSF and TNFa)
were below the lowest detection limit of the assay.
Exposure of BEAS 2B cells to cristobalite at 75 and 150
×1 0
6μm
2/cm
2 for 24 h caused dose-responsive and sig-
nificant release of Interleukin-6 (IL-6), IL-8, IL-12 (p70),
IL-13, regulated on activation normal T-cell expressed
and secreted (RANTES), granulocyte colony-stimulating
factor (G-CSF), basic fibroblast growth factor (bFGF/
FGF-2), platelet-derived growth factor-BB (PDGF-BB),
and vascular endothelial growth factor (VEGF) (Figure
5). Interestingly, amorphous silica, even at the high sur-
face area concentration (150 × 10
6μm
2/cm
2)d i dn o t
induce increased secretion of any of these mediators.
However, amorphous silica induced a significant
decrease in the amount of interleukin-15 (IL-15)
detected in medium, and both cristobalite and amor-
phous silica caused significant decreases in the amounts
of monocyte chemotactic protein-1 (MCP-1; MCAF)
secreted by BEAS 2B cells. Possible roles of IL-12 and
IL-15 have been addressed in mouse inhalation models
of silicosis [53]. However, it appears that innate immu-
nity (as opposed to adaptive responses) plays a much
stronger role in the development of silicosis [54], sug-
gesting that IL-12 may have a less likely role in silica-
induced disease.
It has been shown by others that crystalline silica par-
ticles induce expression and secretion of IL-6 and IL-8
[21,45-49], potent mediators promoting acute phase
responses and inflammation in lung diseases [55-58],
and thus are implicated in silicosis [59]. RANTES and
MCP-1/MCAF are secreted mediators associated with
recruitment of monocytes, lymphocytes, and granulo-
cytes [60]. Increased levels of RANTES and MCP-1/
MCAF expression also have been reported in alveolar
type II cells exposed to crystalline silica [45], though
increased expression of MCP-1 was seen early and had
nearly diminished by 24 hours. Our studies show
decreased levels of MCP-1/MCAF in medium of both
crystalline and amorphous silica exposed BEAS 2B cells.
The decreased levels of secreted MCP-1/MCAF may
indicate a mechanism of lung defense or possibly an
autocrine stimulation/negative feedback loop. In con-
trast, G-CSF is an extremely strong potentiator of neu-
trophilic response and recruitment (as reviewed in [61]),
and is implicated in development of inflammation and
pulmonary fibrosis [19].
In addition to modulators of inflammation, the prolif-
erative and angiogenic factors, bFGF, VEGF and PDGF-
BB were released from BEAS 2B cells exposed to cristo-
balite silica. PDGF-BB, a promoter of angiogenesis and
cell proliferation, is implicated in silicosis and other
pneumoconioses [62,63], and its expression may corre-
late with disease progression. Increased levels of serum
VEGF are also observed in patients with idiopathic
pulmonary fibrosis (IPF) [64]. In contrast, VEGF derived
from myeloid cells is anti-fibrotic in a mouse model of
pulmonary fibrosis [65]. Perhaps the cell of origin or
location of VEGF secretion or the concentration of
VEGF plays pivotal roles in the development and pro-
gression of pulmonary fibrosis.
Our data, consistent with other studies using crystal-
line silica in bronchial epithelial cells, shows that epithe-
lial cells also have the ability to secrete bFGF in
response to crystalline silica [66,67]. However, our study
shows that crystalline silica as opposed to amorphous
silica particles selectively induced bFGF secretion. This
may indicate an autocrine or paracrine role of epithelial
cell-derived bFGF in promoting fibrotic disease as it has
been shown that bFGF promotes fibroblast proliferation
in a transforming growth factor-b (TGF-b) model of
epithelial-mesenchymal transition [68,69] and in the
development and progression of interstitial pulmonary
fibrosis [70]. Additionally, it has been shown that bFGF
is associated with mast cells in human silicotic lungs
[71].
Taken together, a number of pro-inflammatory, prolif-
erative and angiogenic factors are released from lung
epithelial cells, which are initial target cells in silica-
induced disease. How these factors may interact with
and regulate the airway environment is crucial in deli-
neation of the role the epithelium plays in initiation and
progression of silica-induced fibrosis. In addition, pro-
duction and secretion of proliferative and angiogenic
mediators may play a role in the potential carcinogenic
effects of crystalline silica, by inducing excessive cell
proliferation.
Assessment of cell viability and gene expression induced
by silica particles in primary human bronchial epithelial
cells (NHBE)
NHBE cells were used to confirm results from experi-
ments with BEAS 2B cells as these cells are primary as
opposed to immortalized human bronchial epithelial
cells and may be more responsive to particles. Figure 6
shows changes in cell viability and gene expression in
primary NHBE cells by cristobalite and amorphous silica
particles. When compared to BEAS 2B cells, NHBE cells
were more sensitive to the toxicity of silica particles.
After 24 h, both types of silica particles at 15, 75 and
150 × 10
6μm
2/cm
2 caused between 25-46% loss of viable
cells (Figure 6A). Although particle exposures induced
s i g n i f i c a n t( p<0 . 0 5 )d e c r e a s e si nt h ep e r c e n t a g eo f
viable cells compared to unexposed controls, no signifi-
cant differences were observed between toxicity of cris-
tobalite vs. amorphous silica at equal surface area
concentrations. Based on these results, we chose to
expose NHBE cells to cristobalite silica at the lowest
(15) and a higher (75) surface area concentration and
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Page 9 of 18amorphous silica at 75 × 10
6μm
2/cm
2 in microarray
analyses. Cristobalite at 15 × 10
6μm
2/cm
2 induced only
6 significant gene changes, though at the higher dose
(75 × 10
6μm
2/cm
2), 339 significant changes were
detected. Interestingly, this is nearly the same number
of significant changes (333) induced in BEAS 2B cells at
t h es a m ee x p o s u r ec o n c e n t r a t i o n( F i g u r e3 A ) .I na d d i -
tion, amorphous silica at 75 × 10
6μm
2/cm
2, (i.e. half the
dose used in BEAS 2B cells) (Figure 3A), produced only
42 significant changes.
Gene ontology analysis of the gene expression altera-
tions in NHBE cells exposed to silica particles was per-
formed to compare the trends seen in BEAS 2B cells
and to allow examination of similarities and differences
between cells (Figure 6C-E, Additional file 3). The gene
expression pattern of NHBE cells exposed to cristobalite
or amorphous silica particles followed nearly the same
patterns of expression with most gene changes categor-
ized in the realms of cell signaling and proliferation,
apoptosis, protein metabolic process and immune
response.
Table 3 presents the top 10 genes up and down-regu-
lated by cristobalite and amorphous silica particles in
NHBE cells. IL8, at the top of this list, was up-regulated
by cristobalite 4.37 and 28.47-fold at 15 and 75 ×
10
6μm
2/cm
2 respectively. However, there was no
increase in expression by amorphous silica particles.
Interestingly, TXNIP was up-regulated by both
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fold respectively. This protein binds to NLRP3 and pro-
motes inflammasome activation in response to oxidative
stress [72]. Other genes of interest in this table include
BIRC3, BCL2A1 and TNFAIP3,w h i c ha r ei n v o l v e di n
regulation of apoptosis. When comparing the top 10
genes altered in expression by crystalline silica particles
in BEAS 2B and NHBE cells, only one gene, Solute
carrier family 38, member 4 (SLC38A4), a sodium-
dependent amino acid symporter, is common to both
cells (within the top 10). However, when all gene
expression changes by cristobalite silica were compared
in BEAS 2B and NHBE cells (Table 4), we found 60
genes commonly altered (57 up-regulated and 3 down-
regulated). Of these 60 genes, 36 were altered in both
cell types at the same surface area concentration (75 ×
Table 3 Top 10 genes affected by 24 h exposure to silica particles in NHBE
Gene Name (Abbreviation) Fold Change
a
Cristobalite Amorphous
15
b 75
b 75
b
Up-regulated ▲
Interleukin 8 (IL8) 4.37 28.47 NC
Baculoviral IAP repeat-containing 3 (BIRC3) 2.02 19.81 NC
BCL2-related protein A1 (BCL2A1) NC 19.27 NC
Tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) 2.33 17.11 NC
Interleukin 1 family, member 9 (IL1F9) NC 14.14 NC
GTP binding protein over expressed in skeletal muscle (GEM) NC 12.92 NC
CD83 molecule (CD83) NC 11.47 NC
Transcribed locus, strongly similar to NP_006463.2 thioredoxin interacting protein NC 11.09 27.95
Inhibin, beta A (INHBA) NC 10.25 NC
Thioredoxin interacting protein (TXNIP) NC 9.74 31.14
Heat shock 70 kDa protein 1A (HSPA1A) 2.01 7.56 2.57
Crystallin, mu (CRYM) NC 4.97 2.35
G0/G1 switch 2 (G0S2) NC 3.51 3.12
Transcribed locus (BF4328873) NC NC 2.73
Calcium binding tyrosine-(Y)-phosphorylation regulated (CABYR) NC 2.51 2.55
Non-protein coding RNA 84 (NCRNA00084) NC NC 2.53
Sarcoglycan, gamma (35 kDa dystrophin-associated glycoprotein) (SGCG) NC NC 2.50
Cytoplasmic FMR1 interacting protein 2 (CYFIP2) NC NC 2.48
Down-regulated ▼
Sulfatase (SULF1) NC 3.59 NC
Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PPARGC1A) NC 3.52 NC
Solute carrier family 38, member 4 (SLC38A4) NC 3.43 NC
Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 (ALS2CR8) NC 3.18 2.00
Growth arrest-specific 1 (GAS1) NC 2.84 NC
Hexokinase 2 (HK2) NC 2.69 NC
F-box protein 9 (FBXO9) NC 2.68 NC
Hairy/enhancer-of-split related with YRPW motif 1 (HEY1) NC 2.62 NC
CDNA FLJ37852 fis, clone BRSSN2014513 NC 2.61 NC
Growth hormone receptor (GHR) NC 2.59 NC
Solute carrier family 16, member 7 (monocarboxylic acid transporter 2) (SLC16A7) NC 2.50 NC
Transglutaminase 3 (E polypeptide, protein-glutamine-gamma-glutamyltransferase) (TGM3) 2.13 NC NC
Follistatin (FST) NC NC 2.43
Homo sapiens clone FLB9440 PRO2550 mRNA, complete cds NC 2.32 2.18
Ribonucleotide reductase M2 polypeptide (RRM2) NC NC 2.12
PPPDE peptidase domain containing 1 (PPPDE1) NC 2.23 2.06
Top 10 genes in NHBE cells up and down-regulated by 24-hour exposure to cristobalite silica at 15 and 75 × 10
6 μm
2/cm
2 and amorphous silica particles at 75 ×
10
6 μm
2/cm
2.
a Fold change (mRNA) expression (p < 0.05) cut-off ≥ 2.0-fold compared to controls (n = 3).
b Silica particle concentrations: (× 10
6μm
2/cm
2)
NC = No Change
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Page 11 of 18Table 4 Genes commonly affected by 24 h cristobalite exposure in NHBE and BEAS 2B cells
Gene Name (Abbreviation) Fold Change
a
Cell Type
(Cristobalite)
b
NHBE
(75)
BEAS 2B
(75)
BEAS 2B
(150)
Up-regulated ▲
Interleukin 8 (IL8) 28.47 2.12 2.65
BCL2-related protein A1 (BCL2A1) 19.27 NC 3.08
Tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) 17.11 2.23 2.95
GTP binding protein overexpressed in skeletal muscle (GEM) 12.92 NC 2.13
Inhibin, Beta A (INHBA) 10.25 2.24 3.62
Interleukin 24 (IL24) 7.62 3.88 8.54
Heat shock 70 kDa protein 1A (HSPA1A) 7.56 NC 2.34
Chemokine (C-X-C motif) ligand 3 (CXCL3) 7.42 NC 2.42
TNF receptor-associated factor 1 (TRAF1) 7.30 2.86 4.22
Radical S-adenosyl methionine domain containing 2 (RSAD2) 6.92 5.45 23.25
Early growth response 1 (EGR1) 6.72 2.65 4.63
Coiled-coil domain containing 85B (CCDC85B) 6.46 3.44 6.11
FOS-like antigen 1 (FOSL1) 5.80 2.47 3.18
Early growth response 3 (EGR3) 5.31 NC 2.65
Jun oncogene (JUN) 4.99 NC 2.00
Matrix metallopeptidase 1, interstitial collagenase (MMP1) 4.99 16.12 44.68
2’-5’-oligoadenylate synthetase-like (OASL) 4.20 NC 18.85
cAMP responsive element binding protein 5 (CREB5) 3.87 3.25 4.10
Transcribed locus, strongly similar to NP_000337.1 transcription factor SOX9 (SOX9) 3.84 NC 2.12
Interferon induced with helicase C domain 1(IFIH1) 3.79 NC 3.86
Heat shock 70 kDa protein 6 (HSP70B’) 3.70 4.08 14.39
Kynureninase (L-kynurenine hydrolase) (KYNU) 3.66 NC 2.19
Prostaglandin-endoperoxide synthase 2 (PTGS2) 3.56 NC 2.54
Superoxide dismutase 2, mitochondrial (SOD2) 3.53 NC 2.86
Interleukin 1 receptor-like 1 (IL1RL1) 3.52 2.89 5.36
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) 3.45 6.01 16.26
Interferon-induced protein 44 (IFI44) 3.36 7.51 19.90
Nuclear receptor subfamily 1, group D, member 1 (NR1D1) 3.24 3.01 4.72
Interferon stimulated exonuclease gene 20 kDa (ISG20) 3.21 NC 2.48
Plasminogen activator, urokinase receptor (PLAUR) 3.14 NC 2.35
Transmembrane protein 40 (TMEM40) 3.06 NC 4.15
Distal-less homeobox 2 (DLX2) 2.99 2.34 3.78
Niacin receptor 2 (NIACR2 OR GPR109B) 2.87 3.14 NC
Human 28S ribosomal RNA gene, complete cds. (RNA28S1) 2.86 NC 2.21
Histone deacetylase 9 (HDAC9) 2.84 3.24 NC
2’-5’-oligoadenylate synthetase 1, 40/46 kDa (OAS1) 2.83 NC 20.53
Nuclear receptor subfamily 4, group A, member 3 (NR4A3) 2.79 2.58 3.49
Oxidative stress induced growth inhibitor 1 (OSGIN1) 2.79 NC 2.48
Smoothelin (SMTN) 2.74 2.38 2.72
Heme oxygenase (decycling) 1 (HMOX1) 2.69 NC 2.57
Basic helix-loop-helix family, member e41 (BHLHE41) 2.64 NC 2.34
ADAM metallopeptidase domain 8 (ADAM8) 2.62 NC 2.08
Crystallin, alpha B (CRYAB) 2.58 2.26 2.67
Colony stimulating factor 2 (granulocyte-macrophage) (CSF2) 2.53 4.20 7.37
Calcium binding tyrosine-(Y)-phosphorylation regulated (CABYR) 2.51 NC 2.19
Chromosome 1 open reading frame 38 (C1orf38) 2.44 NC 3.04
2’-5’-oligoadenylate synthetase 3, 100 kDa (OAS3) 2.29 2.41 3.84
Sprouty homolog 4 (Drosophila) (SPRY4) 2.26 2.98 4.64
Dual specificity phosphatase 5 (DUSP5) 2.23 2.02 2.61
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6μm
2/cm
2) and 57 were commonly altered in NHBE
cells at 75 × 10
6μm
2/cm
2 vs. BEAS 2B at 150 × 10
6μm
2/
cm
2. It should be noted that 60 genes may not appear
to be a large portion of over 300 genes altered by cristo-
balite. However, the majority of these genes have strong
connections with potential mechanisms of crystalline
silica-induced disease, namely inflammation, fibrotic
processes, as well as cell proliferation/anti-apoptosis
(carcinogenesis).
Within this list of commonly affected genes there are
a number of transcription factors, cytokines/chemokines
and receptors, oxidative stress-related, and genes related
to the regulation of apoptosis, proliferation, cell signal-
ing and ECM breakdown. The transcription factors,
FOSL1 (fra-1), FOSB and,J U N , members of the AP-1
complex family, as well as CREB5, which can also inter-
act with jun family members, were up-regulated by cris-
tobalite in both cell lines. The AP-1 transcription factor
complex appears to play a major role in cellular
response to crystalline silica [50]. In addition, the tran-
scriptional regulators EGR1 and EGR3 were induced by
cristobalite silica.
A number of pro-inflammatory mediators were also
increased at the mRNA level by cristobalite in NHBE
and BEAS 2B cells including, IL1A, IL6, IL8, IL24,
CXCL3,( M I P - 2 b), CSF2 (GM-CSF) and the IL1RL1.
Some of these genes (IL1A, IL1RL1) and their proteins
are involved in regulation and activity of the NALP3
inflammasome, a signaling complex that responds to
“danger signals” and promotes an inflammatory
response after addition of silica to human THP-1
macrophages [73]. In line with the hypothesis that oxi-
dative stress mediates inflammasome activity by silica,
oxidative-stress response-genes, PTGS2 (COX2), SOD2
(MnSOD), HMOX1 and OSGIN1 were also up-regulated
by cristobalite in NHBE and BEAS 2B cells. These find-
ings also reinforce the observations that inflammation
and oxidative stress are two of the driving forces in
silica-induced disease mechanisms [74]. Inflammation
and oxidative stress create an imbalanced cellular envir-
onment, with cellular injury, and death or cell prolifera-
tion. These mechanisms may contribute to airway
remodeling and indirect mechanisms of carcinogenicity,
promoting a favorable microenvironment for both fibro-
sis and tumor formation.
A number of other genes were also altered in expres-
sion by cristobalite in both cell lines, including genes
involved in ECM breakdown (MMP1 and PLAUR),
genes involved in cell signaling regulation (HDAC9), and
regulators of MAPK signaling (SPRY4 and DUSP5).
Other genes are involved in anti-viral activity and inter-
feron-response including, RSAD2, OAS1, OAS3, OASL,
IFIH1, IFIT2, IFI44 and ISG20.O ft h o s eg e n e s ,IFIT1
and IFI44 were up-regulated in both cell types by amor-
phous silica particles as well.
Conclusions
Particulates, especially in the realm of nanotoxicology,
are rapidly becoming a question of concern regarding
health effects in occupational setting as well as in the
environment. Our studies and a recent report in the lit-
erature [41] demonstrate that gene expression profiling
in human lung epithelial cells in vitro can be used to
determine the relative pathogenicity of potentially harm-
ful particulates (i.e. crystalline silica and airborne parti-
culate matter, respectively) as opposed to viability
studies and metabolic testing. Changes in expression of
genes related to inflammation, oxidative stress, and pro-
liferation as well as the secretion of proinflammatory,
angiogenic and proliferative cytokines and chemokines
Table 4 Genes commonly affected by 24 h cristobalite exposure in NHBE and BEAS 2B cells (Continued)
Ring finger protein 39 (RNF39) 2.22 2.47 3.65
Leukemia inhibitor factor (Cholinergic differentiation factor) (LIF) 2.21 2.96 4.73
Sphingosine kinase 1 (SPHK1) 2.11 3.20 4.88
Interleukin 6 (Interferon, beta 2) (IL6) 2.10 2.12 2.59
Interleukin 1, alpha (IL1A) 2.09 3.97 6.17
FBJ murine osteosarcoma viral oncogene homolog B (FOSB) 2.07 3.65 6.37
Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (PAI2) 2.04 2.16 4.33
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (DDX60) 2.02 2.26 5.01
Down-regulated ▼
Sulfatase 1 (SULF1) 3.59 2.01 2.10
Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PPARGC1A) 3.52 2.85 3.75
Chromosome 5 open reading frame 13 (C5orf13) 2.05 NC 2.21
Sixty genes (57 up-regulated and 3 down-regulated) found commonly altered by exposure to cristobalite silica in NHBE cells and BEAS 2B cells from microarray
analysis. Genes are listed in descending order of fold-change compared to controls seen in NHBE cells.
a Fold change (mRNA) expression (p < 0.05) cut-off ≥ 2.0-fold compared to controls (n = 3)
b Cristobalite silica particle concentrations: (× 10
6μm
2/cm
2)
NC = No Change
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lium to crystalline silica particles and their relation to
development of fibrosis [12].
Our studies compared two particles of the same che-
mical make up (SiO2), but of different habit (i.e. crystal-
line vs. amorphous). The responses observed suggest
that the crystallinity of cristobalite may dictate early
molecular responses as well as dissolution of particles
over time in the lung. Moreover, we show that the mag-
nitude and patterns of differential gene expression by
crystalline silica are similar in both BEAS 2B and NHBE
cells, suggesting that immortalized and established
epithelial cell lines can be used as in vitro models to
predict the pathogenicity of potentially harmful respir-
able particulates as opposed to expensive and time-con-
suming isolation of human primary cells and animal
inhalation studies.
Methods
Human Bronchial Epithelial Cell Cultures
Non-tumorigenic human bronchial epithelial cells
(Ad12-SV40 immortalized) BEAS 2B (ATCC, Manassas,
VA) were grown and maintained in DMEM/F12 50:50
media containing 10% Fetal Bovine Serum (FBS) (Cell-
Gro
® Mediatech inc, Manassas, VA), with penicillin (50
units/ml), streptomycin (100 μg/ml) (Invitrogen, Carls-
bad, CA), hydrocortisone (100 μg/ml), insulin (2.5 μg/
ml), transferrin (2.5 μg/ml) and selenium (2.5 μg/ml)
(Sigma, St. Louis, MO). BEAS 2B cells culture flasks and
plates (BD, Franklin Lakes, NJ) were pre-coated with a
mixture of fibronectin (Sigma, St. Louis, MO) (0.01 mg/
ml), bovine collagen type I (0.03 mg/ml) (Invitrogen,
Carlsbad, CA) and bovine serum albumin (0.01 mg/ml)
(Sigma, St. Louis, MO), dissolved in DMEM/F12 media
for 24 hours at 37°C prior to culturing cells. Prior to
exposures, medium was aspirated and replaced with a
reduction medium containing 0.5% FBS. Primary normal
human bronchial epithelial cells (NHBE-17917) were
purchased from Lonza, Clonetics
®. NHBE cells were
cultured and maintained in BEGM
® and with Reagent-
pack™subculture reagents (Trypsin/EDTA, Trypsin
Neutralizing Solution and Hepes-buffered saline solu-
tion), all purchased from Lonza, Clonetics
®.( S w i t z e r -
land) were used for subculture following manufacturers
protocol.
Synthesis, Characterization, and Determination of Surface
Areas of Silica Particles
The amorphous silica microparticles were prepared
according to the procedure of De et al [75] in the
Department of Chemistry, University of Vermont, Bur-
lington, VT, USA. Briefly, tetraethylorthosilicate (32.0 g,
0.143 mol) was combined with water (11.0 g, 0.611 mol)
and stirred rapidly (600 rpm) to form an emulsion. To
this emulsion was rapidly added glacial acetic acid (36.8
g, 0.643 mol), and stirring was continued for 60 s, at
which point stirring was terminated. The mixture was
then allowed to sit quiescently for 45 min. Afterward
the particles were filtered and washed extensively with
water (5 mL × 4) and ethanol (5 mL × 3). After air-dry-
ing for several hours, the particles were dried overnight
under vacuum, then particles were calcined at 550°C for
12 hours under air. Finally, the particles were ground
with a mortar and pestle to yield a freely-flowing, white
powder (4.8 g, 56% yield). Samples were mounted for
SEM by dusting onto carbon tape applied to aluminum
sample stubs. They were then sputter coated with Pd/
Au for 3.5 minutes in a Polaron sputter coater (Model
5100). Specimens were then examined with a JSM 6060
scanning electron microscope (JEOL USA, Inc., Peabody,
MA) operating at an accelerating voltage of 25 kV and a
working distance of 10 mm. Size distribution was deter-
mined using SEM images by measuring the diameter of
300-400 silica particles (5 fields of view) using Meta-
morph offline software version 7.7.3 64 bit (Molecular
Devices, Sunnyvale, CA). Cristobalite silica was exam-
ined by powder X-ray diffraction methods using a
Rigaku MiniFlexII X-ray diffractometer. Rietveld analy-
sis, as implemented in the Rigaku WPPF program, was
undertaken with eight-second fixed time scans at 0.02°
steps from 10° to 100° 2θ. For the scan, Rwp = 10.94%,
modelled with a-quartz and cristobalite. The quantita-
tive analysis by Rietveld analysis yielded 95.5(± 0.03)%
cristobalite, and 4.54(0.08)% quartz. Surface area of par-
ticles was determined by BET nitrogen adsorption analy-
sis. Nitrogen adsorption and desorption isotherms were
obtained on a Micromeritics TriStar instrument after
samples were degassed overnight under vacuum. Surface
areas were measured using the BET method, and pore
size distributions were calculated from a modified KJS
method using the adsorption branch [76-78].
Particle Exposure to Cells
Prior to exposure, particles were weighed in scintillation
vials and placed under UV light overnight to be steri-
lized. Particles were then submerged in Hanks’ Balanced
Salt Solution (HBSS) (CellGro
® Mediatech inc, Mana-
ssas, VA) at (1.0-2.0 mg/ml). Particle suspensions were
sonicated in a waterbath sonicator for 15 minutes fol-
lowed by being trichurated 5 times through a 22-gauge
needle. Suspensions were then administered to cell cul-
ture plates and briefly shaken to assure dispersion of
particles before they settle.
Assessment of Cell Viability
After 24 h, cells were collected by detatching with 0.25%
Trypsin (Invitrogen, Carlsbad, CA) solution in HBSS,
and a final volume of 1.5 ml (0.5 ml trypsin solution +
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tion was diluted 1:5 in a solution of 0.4% trypan blue
(MP Biomedicals, Solon, OH), which is a dye retained
by dead cells and excluded by viable cells and HBSS.
After 5 min, unstained viable cells were counted using a
hemocytometer to determine the total number of viable
cells per dish and particle exposed groups were com-
pared unexposed controls as described previously [79]
For each group (particle type/concentration) n = 3 and
experiments were performed in triplicate (BEAS 2B) and
duplicate (NHBE).
Scanning Electron Microscopy
For imaging of cristobalite silica and amorphous silica
particles, 0.0029 or 0.0026 g was diluted to a final con-
centration of 1.45 and 1.3 μg/ml (4.0 ml total volume),
respectively, in a solution of 6% ethanol and ddH2Ob y
serial dilution. Silica particle dilutions were filtered
through a 0.4 μm Nucleopore Track-Etch membrane
(Fisher Scientific, Pittsburgh, PA) followed by a rinse
with 1.0 ml 100% ethanol and drying overnight. Half of
the dried filter was adhered to a standard aluminum
specimen stub with graphite point (Electron Microscope
Sciences, Hatfield, PA) followed by sputter coating with
gold and palladium using a Polaron sputter coater
(Model 5100; Quorum Technologies, East Sussex, UK)
Specimens were imaged and EDS analysis was per-
formed using an INCA 350 × Max detector and INCA
Energy System software (Oxford Instruments, Concord,
MA) by “point-analysis”. BEAS 2B cells were grown on
Thermonox plastic cover slips (Nalge Nunc Interna-
tional, Naperville, IL). Prior to seeding cells, cover slips
were coated with fibronectin (0.01 mg/ml), bovine col-
lagen type I (0.03 mg/ml) and bovine serum albumin
(0.01 mg/ml) dissolved in DMEM/F12 medium for 24 h
at 37°C. Cells were grown to near confluency and then
put in reduction medium (0.5% FBS) 24 h prior to incu-
bation with particles. Cells were exposed to silica parti-
cles for 2 and 24 h before fixation. Cells were fixed with
2% glutaraldehyde in 0.1 M phosphate buffered saline
(PBS) for 1 h at 4°C. Samples then rinsed for 5 min in
PBS (3×) and then (1×) 5 minutes in 0.05 M cacodylate
buffer (pH 7.2). Samples then post-fixed with 1%
osmium tetroxide in 0.05 M cacodylate buffer (pH7.2)
for 1 h at room temperature, then rinsed (3×) for 5 min
in 0.05 M cacodylate buffer. Samples immersed in 1%
tannic acid in 0.05 M cacodylate buffer for 1 h at room
temperature and in the dark (covered with foil), rinsed
1× for 5 min in cacodylate buffer and 3× for 5 min in
distilled water. Samples incubated with 0.5% uranyl acet-
ate in distilled water for 1 hr at room temperature in
the dark (covered with foil), rinsed 3× for 5 min in dis-
tilled water, and stored in 0.05 M cacodylate buffer at 4°
C. Cover slips were put in cylindrical holder and
dehydrated in ethanol series: using 10 min changes in
35, 50, 70, 85% up to 95% ethanol, then (2×) 20 min
changes in 95% ethanol, followed by three 15 min
changes in anhydrous 100% ethanol. Samples were then
critical-point dried and fixed to aluminium specimen
mounts with carbon paint and dried overnight in a
desiccator. Samples were then sputter-coated with gold
and palladium in a Polaron sputter coater (Model 5100)
and imaged on JSM-6060 scanning electron microscope
(JEOL USA, Inc. Peabody, MA).
RNA Isolation and Microarray Profiling
Total RNA was prepared using an RNeasy
® Plus Mini
Kit according to the manufacturers’ protocol (Qiagen,
Valencia, CA), as published previously [80]. All proce-
dures were performed by the Microarray analysis core
facility of the Vermont Genetics Network (VGN) using
a standard Affymetrix protocol as described previously
[80,81]. GeneChip
® Human Genome U133A 2.0 arrays
(Affymetrix, Santa Clara, CA) targeting 18,400 human
transcripts were scanned twice (Hewlett-Packard Gen-
eArray Scanner), the images overlaid, and the average
intensities of each probe cell compiled. Microarray data
were analyzed using GeneSifter software (VizX Labs,
Seattle, WA). This program used a t-test for pair- wise
comparison and a Benjamini-Hochberg test for false dis-
covery rate (FDR 5%) to adjust for multiple compari-
sons. A 2-fold cutoff limit was used for analysis (only
genes up or down-regulated ≥ 2.0-fold vs. unexposed
controls)
Quantitative Real-time Polymerase Chain Reaction (qRT-
PCR)
Total RNA (1 μg) was reverse-transcribed with random
primers using the AMV Reverse Transcriptase kit (Pro-
mega, Madison, WI) according to the recommendations
of the manufacturer, as described previously [80]. All
Taqman
® qRT-PCR was performed using Assays-On-
Demand™ primer and probe sets used for Applied Bio-
systems (Foster City, CA) and performed as described
previously [31].
Bio-Plex Analysis of Cytokines and Chemokines in
Medium of BEAS 2B Cells
To quantify cytokine, chemokine, and growth factor
levels in conditioned medium of BEAS 2B cells exposed
to silica particles, a multiplex suspension protein array
was performed using the Bio-Plex
® protein array system
and a human cytokine 27-plex panel (Bio-Rad, Hercules,
CA), as previously described [80]. A sample of 0.05%
FBS medium alone was also run to account for back-
ground levels of secreted proteins. Data are expressed as
pg of cytokine/mL of conditioned medium (mean ±
SEM), with N = 3 for each group.
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Statistical analysis of results from cell viability and Bio-
Plex analysis were evaluated by analysis of variance
(ANOVA) using the Student Neuman-Keul’s procedure
for adjustment of multiple pair-wise comparisons
between treatment groups. Significant differences in
gene expression values determined by qRT-PCR were
evaluated using a Student’s t-test. Differences with p
values < 0.05 were considered statistically significant.
Additional material
Additional file 1: SEM Imaging and EDS Analysis of Silica Particles.
SEM images of filtered (A) cristobalite silica and (B) amorphous silica
particles with respectful electron dispersive spectroscopy (EDS) spectra
showing their identical chemical composition. Images are at a
magnification of 1500× and scale bars equal to 10 μm. Black arrows
indicate the points analyzed by EDS “point-analysis”, spectra represent
points indicated. Silicon (Si) and oxygen (O) peaks of each particle type
indicate both are pure silica particles. Gold (Au) and palladium (Pd) peaks
are present due to the gold and palladium sputter-coating, carbon (C) is
present because of graphite paint used to mount particle filters.
Additional File 2: Silica Particle Size Distrbution. Histograms represent
size-distribution of cristobalite silica particles (A) and amorphous silica
particles (B). Particles were filtered and imaged by SEM at 1000×
magnification. The diameter of each particle was recorded using
Metamorph
®®, and 300-400 particles (5 fields/stub) were measured for
each type of silica particle.
Additional file 3: Gene Ontology of BEAS 2B and NHBE Exposed to
Silica Particles for 24 h (%Total/Category). Pie charts (A-F) represent
gene ontology analysis of alterations in gene expression of BEAS 2B cells
(A-C) exposed to (A) cristobalite 75 × 10
6μm
2/cm
2,( B) cristobalite 150 ×
10
6μm
2/cm
2 and (C) amorphous silica 150 × 10
6μm
2/cm
2. Gene ontology
of NHBE cells (D-F) exposed to (D) cristobalite 15 × 10
6μm
2/cm
2,( E)
cristobalite 75 × 10
6μm
2/cm
2 and amorphous silica 75 × 10
6μm
2/cm
2.
Ten categories of interest were analyzed and charts represent the
percent (%) of total genes altered in each category for each exposure
group.
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